Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alfonso Segarra-Medrano"'
Autor:
Immaculada Comas-Reixach, José-Bruno Montoro-Ronsano, Josep-Maria Suñé-Negre, Albert Blanco-Grau, Alfonso Segarra-Medrano, Maria-Eugenia Palacio-Lacambra
Publikováno v:
British Journal of Clinical Pharmacology. 84:2120-2128
Aims Accurately estimating kidney function is essential for the safe administration of renally cleared drugs such as ganciclovir. Current practice recommends adjusting renally eliminated drugs according to the Cockcroft-Gault equation. There are no d
Autor:
Alfonso Segarra Medrano, Elías Jatem Escalante, Elena Ostos Roldán, Natalia Ramos Terrades, Karla Viviana Arredondo Agudelo, Irene Agraz Pamplona, Naiara Valtierra Carmeno, Maria Teresa Salcedo Allende, Juliana Jaramillo Vasquez, Clara Carnicer Cáceres
Publikováno v:
Biomarkers. 20:77-83
Context: The dynamics of anti-phospholipase A2 antibody titers during treatment could predict clinical responses in patients with membranous nephropathy.Objectives: We analyzed the predictive value of the dynamics of these antibodies on clinical resp
Autor:
Alfonso, Segarra-Medrano, Elías, Jatem-Escalante, M Teresa, Quiles-Pérez, M Teresa, Salcedo, M Antonia, Arbós-Via, Helena, Ostos, Naiara, Valtierra, Clara, Carnicer-Cáceres, Irene, Agraz-Pamplona
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 34(3)
The M-type phospholipase A2 receptor (PLA2R) has been identified as one of the target antigens of the autoimmune response in idiopathic membranous nephropathy (MN). The prevalence of anti-PLA2R antibodies in patients with idiopathic MN is around 70%
Autor:
Alfonso, Segarra-Medrano, Elias, Jatem-Escalante, Irene, Agraz-Pamplona, Clara, Carnicer-Cáceres, Natalia, Ramos-Terrades, Elena, Ostos-Roldán, M Teresa, Quiles-Pérez, M Antonia, Arbós-Via
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 33(4)
Half of patients with nephrotic syndrome caused by primary focal segmental glomerulosclerosis (FSGS) have resistance to treatment with steroids. In the case of corticosteroid resistance,nbsp;the best evidence-based option has classically been treatme
Autor:
Alfonso, Segarra-Medrano, Clara, Carnicer-Cáceres, M Antonia, Arbós-Via, M Teresa, Quiles-Pérez, Irene, Agraz-Pamplona, Elena, Ostos-Roldán
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 32(5)
One of the major challenges modern nephrology should face is the identification of biomarkers that are associated with histopathological patterns or defined pathogenic mechanisms that might aid in the non-invasive diagnosis of the causes of nephrotic
Autor:
Miquel Vilardell Tarrés, Josefina Cortés-Hernández, Josep Ordi-Ros, Alfonso Segarra Medrano, Maria Teresa Torres-Salido
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 25(12)
Background Although mycophenolate mofetil (MMF) is being increasingly used to manage lupus nephritis (LN), long-term experience is limited. Despite treatment, a significant proportion of patients will be refractory to this regime. Methods We report,
Autor:
Vicente Ortún, José R. Banegas, María Teresa Olcoz Chiva, Manuel Conde Herrera, Salvador Peiró Moreno, Ricard Meneu de Guillerna, Carlos Rodríguez Pascual, Ramón Hernández-Vecino, Fernando Rodríguez Artalejo, Alfonso Segarra Medrano, Beatriz González López-Valcárcel
Publikováno v:
Revista Española de Salud Pública. 77:657-657